Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2024The Journal of Experimental MedicineOpen Access

SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

APAna PortelinhaMemorial Sloan Kettering Cancer CenterSWShenqiu WangMemorial Sloan Kettering Cancer CenterSPS. ParsaUniversity of Bern

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Portelinha et al. (2024) studied this question.

synapsesocial.com/papers/68e5943fb6db64358752eecfhttps://doi.org/10.1084/jem.20231143
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells2019 · 382 citations
  2. 2Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing2013 · 400 citations
  3. 3The H3K4 methyltransferase Setd1a is first required at the epiblast stage, whereas Setd1b becomes essential after gastrulation2014 · 200 citations
  4. 4iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry2016 · 140 citations
  5. 5The Function and Regulation of the JARID1 Family of Histone H3 Lysine 4 Demethylases: the Myc Connection2007 · 89 citations